Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis

被引:648
作者
Zhao, Xiaofeng [1 ,2 ]
Guan, Jun-Lin [1 ,2 ,3 ]
机构
[1] Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Med, Dept Internal Med, Div Genet, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA
关键词
FAK; Cell migration; Angiogenesis; Signal transduction; Cancer; GTPASE-ACTIVATING PROTEIN; VASCULAR ENDOTHELIAL-CELLS; TYROSINE KINASE; CANCER-CELLS; GROWTH-FACTOR; FERM DOMAIN; DEPENDENT FUNCTIONS; NULL CELLS; LD4; MOTIF; FAK;
D O I
10.1016/j.addr.2010.11.001
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Focal adhesion kinase (FAK) is a cytoplasmic tyrosine kinase that plays critical roles in integrin-mediated signal transductions and also participates in signaling by other cell surface receptors. In integrin-mediated cell adhesion, FAK is activated via disruption of an auto-inhibitory intra-molecular interaction between its amino terminal FERM domain and the central kinase domain. The activated FAK forms a complex with Src family kinases, which initiates multiple downstream signaling pathways through phosphorylation of other proteins to regulate different cellular functions. Multiple downstream signaling pathways are identified to mediate FAK regulation of migration of various normal and cancer cells. Extensive studies in cultured cells as well as conditional FAK knockout mouse models indicated a critical role of FAK in angiogenesis during embryonic development and cancer progression. More recent studies also revealed kinase-independent functions for FAK in endothelial cells and fibroblasts. Consistent with its roles in cell migration and angiogenesis, increased expression and/or activation of FAK are found in a variety of human cancers. Therefore, small molecular inhibitors for FAK kinase activity as well as future development of novel therapies targeting the potentially kinase-independent functions of FAK are promising treatments for metastatic cancer as well as other diseases. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:610 / 615
页数:6
相关论文
共 93 条
[1]   EXPRESSION OF AN N-TERMINALLY TRUNCATED FORM OF HUMAN FOCAL ADHESION KINASE IN BRAIN [J].
ANDRE, E ;
BECKERANDRE, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 190 (01) :140-147
[2]   Endothelial FAK is essential for vascular network stability, cell survival, and lamellipodial formation [J].
Braren, R ;
Hu, HQ ;
Kim, YH ;
Beggs, HE ;
Reichardt, LF ;
Wang, R .
JOURNAL OF CELL BIOLOGY, 2006, 172 (01) :151-162
[3]   REQUIREMENT OF VASCULAR INTEGRIN ALPHA(V)BETA(3) FOR ANGIOGENESIS [J].
BROOKS, PC ;
CLARK, RAF ;
CHERESH, DA .
SCIENCE, 1994, 264 (5158) :569-571
[4]   ANTIINTEGRIN ALPHA-V-BETA-3 BLOCKS HUMAN BREAST-CANCER GROWTH AND ANGIOGENESIS IN HUMAN SKIN [J].
BROOKS, PC ;
STROMBLAD, S ;
KLEMKE, R ;
VISSCHER, D ;
SARKAR, FH ;
CHERESH, DA .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (04) :1815-1822
[5]  
Cary LA, 1996, J CELL SCI, V109, P1787
[6]   Identification of p130Cas as a mediator of focal adhesion kinase-promoted cell migration [J].
Cary, LA ;
Han, DC ;
Polte, TR ;
Hanks, SK ;
Guan, JL .
JOURNAL OF CELL BIOLOGY, 1998, 140 (01) :211-221
[7]   Dissemination and growth of cancer cells in metastatic sites [J].
Chambers, AF ;
Groom, AC ;
MacDonald, IC .
NATURE REVIEWS CANCER, 2002, 2 (08) :563-572
[8]   Roles of Rho-associated kinase and myosin light chain kinase in morphological and migratory defects of focal adhesion kinase-null cells [J].
Chen, BH ;
Tzen, JTC ;
Bresnick, AR ;
Chen, HC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (37) :33857-33863
[9]   Regulation of the PH-domain-containing tyrosine kinase Etk by focal adhesion kinase through the FERM domain [J].
Chen, RY ;
Kim, O ;
Li, M ;
Xiong, XS ;
Guan, JL ;
Kung, HJ ;
Chen, HG ;
Shimizu, Y ;
Qiu, Y .
NATURE CELL BIOLOGY, 2001, 3 (05) :439-444
[10]   Regulation of cell contraction and membrane ruffling by distinct signals in migratory cells [J].
Cheresh, DA ;
Leng, J ;
Klemke, RL .
JOURNAL OF CELL BIOLOGY, 1999, 146 (05) :1107-1116